Cullinan Oncology, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BIOIMPACT CAPITAL LLC | 02/14/2025 | 7.65 M | $93.16 M | 0.00% | 13.11% |
| BVF INC/IL | 02/14/2025 | 5.75 M | $70.04 M | 0.00% | 9.86% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 4.37 M | $53.24 M | 0.74% | 7.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/14/2025 | 3.38 M | $41.16 M | 3.03% | 5.79% |
| VANGUARD GROUP INC | 02/11/2025 | 2.94 M | $35.76 M | -2.08% | 5.03% |
| BLUE OWL CAPITAL HOLDINGS LP | 02/14/2025 | 2.37 M | $28.88 M | 17.90% | 4.06% |
| FRANKLIN RESOURCES INC | 02/12/2025 | 2.20 M | $26.79 M | 0.39% | 3.77% |
| STATE STREET CORP | 02/14/2025 | 2.12 M | $25.88 M | -9.10% | 3.64% |
| ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 2.01 M | $24.50 M | 8.47% | 3.45% |
| ORBIMED ADVISORS LLC | 02/14/2025 | 1.94 M | $23.66 M | 81.54% | 3.33% |
| RTW INVESTMENTS, LP | 02/14/2025 | 1.71 M | $20.78 M | 0.00% | 2.92% |
| VR ADVISER, LLC | 02/14/2025 | 1.38 M | $16.81 M | 0.00% | 2.37% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 1.32 M | $16.06 M | 28.89% | 2.26% |
| LYNX1 CAPITAL MANAGEMENT LP | 02/14/2025 | 1.26 M | $15.32 M | 206.16% | 2.16% |
| KYNAM CAPITAL MANAGEMENT, LP | 02/14/2025 | 1.25 M | $15.26 M | 100.00% | 2.15% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.21 M | $14.80 M | 0.51% | 2.08% |
| SIREN, L.L.C. | 02/14/2025 | 1.21 M | $14.75 M | 0.00% | 2.08% |
| BRAIDWELL LP | 02/14/2025 | 1.18 M | $14.33 M | 0.00% | 2.02% |
| NEXTECH INVEST LTD. | 02/14/2025 | 1.14 M | $13.90 M | 0.00% | 1.96% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 1.03 M | $12.55 M | -24.00% | 1.77% |
| TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 921,138 | $11.22 M | 0.00% | 1.58% |
| 02/14/2025 | 907,895 | $11.06 M | 100.00% | 1.56% | |
| PATIENT SQUARE CAPITAL LP | 02/14/2025 | 878,897 | $10.70 M | 6.57% | 1.51% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 833,962 | $10.16 M | 5.76% | 1.43% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 742,114 | $9.04 M | 0.71% | 1.27% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 685,374 | $8.35 M | -2.17% | 1.17% |
| FORESITE CAPITAL MANAGEMENT V, LLC | 02/14/2025 | 657,905 | $8.01 M | 0.00% | 1.13% |
| MARSHALL WACE, LLP | 02/13/2025 | 651,693 | $7.94 M | -38.16% | 1.12% |
| FORESITE CAPITAL MANAGEMENT VI LLC | 02/14/2025 | 634,558 | $7.73 M | 100.00% | 1.09% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 02/13/2025 | 595,489 | $7.25 M | 0.00% | 1.02% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 580,136 | $7.07 M | 3.43% | 0.99% |
| AMERIPRISE FINANCIAL INC | 02/14/2025 | 504,264 | $6.14 M | 20.78% | 0.86% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 430,971 | $5.25 M | 1.65% | 0.74% |
| 02/13/2025 | 276,400 | $3.37 M | 100.00% | 0.47% | |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2025 | 263,817 | $3.21 M | 0.00% | 0.45% |
| BARCLAYS PLC | 02/13/2025 | 245,231 | $2.99 M | -1.36% | 0.42% |
| UBS GROUP AG | 02/14/2025 | 235,713 | $2.87 M | 27.03% | 0.40% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 227,033 | $2.77 M | -2.80% | 0.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 02/14/2025 | 205,000 | $2.50 M | 10.29% | 0.35% |
| JPMORGAN CHASE & CO | 02/12/2025 | 198,214 | $2.41 M | 580.91% | 0.34% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 190,508 | $2.32 M | -32.40% | 0.33% |
| WOODLINE PARTNERS LP | 02/14/2025 | 167,315 | $2.04 M | 100.00% | 0.29% |
| WALLEYE CAPITAL LLC | 02/13/2025 | 156,497 | $1.91 M | -52.35% | 0.27% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 137,616 | $1.68 M | -0.53% | 0.24% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/14/2025 | 133,260 | $1.62 M | -1.32% | 0.23% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 132,976 | $1.62 M | 25.42% | 0.23% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 130,647 | $1.59 M | 100.00% | 0.22% |
| VOSS CAPITAL, LLC | 02/13/2025 | 122,361 | $1.49 M | 100.00% | 0.21% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 115,000 | $1.40 M | 100.00% | 0.20% |
| KENNEDY CAPITAL MANAGEMENT LLC | 02/13/2025 | 111,049 | $1.35 M | 100.00% | 0.19% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cullinan Oncology, Inc. institutional Ownership - FAQ's
During the previous two years, 167 institutional investors and hedge funds held shares of Cullinan Oncology, Inc.. The most heavily invested institutionals were:
BioImpact Capital LLC: 7.65 M
BVF INC/IL: 5.75 M
BlackRock Funding, Inc. /DE: 4.37 M
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 3.38 M
VANGUARD GROUP INC: 2.94 M
Blue Owl Capital Holdings LP: 2.37 M
112.42% of Cullinan Oncology, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 71.83 M shares in the last 24 months. This purchase volume represents approximately $846.14 M in transactions.